GlaxoSmithKline News

Achievements and Progress Heading Into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook

GlobeNewswireDec 26 09:00 ET

Pfizer's Progress on C. Diff Vaccine and Pneumococcal Shot Wins Analyst Conviction

Analyst UpgradesDec 23 13:20 ET

GSK COVID Antiviral Authorization for Sotrovimab Revoked by FDA

Seeking AlphaDec 23 12:55 ET

GlaxoSmithKline (GSK) Gets a Hold From Barclays

TipRanksDec 20 13:15 ET · Ratings

Express News | GSK Announced Headline Results From FIRST-ENGOT-OV44 Phase 3 Trial Of Zejula (Niraparib) And Jemperli (Dostarlimab) In First Line Advanced Ovarian Cancer, The Trial Met Its Primary Endpoint Of Progression-free Survival, The Key Secondary Endpoint Of...

BenzingaDec 20 04:01 ET

GSK's Combination of Cancer Drugs Shows Positive Results in Late-Stage Trial

WSJDec 20 02:44 ET

GSK's Ovarian Cancer Treatment Meets Primary Endpoint in Late-stage Study

MT NewswiresDec 20 02:37 ET

Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services

BenzingaDec 19 13:38 ET

GlaxoSmithKline (GSK) Gets a Hold From Goldman Sachs

TipRanksDec 19 11:55 ET · Ratings

GSK (GSK.US) monoclonal antibody first-line therapy has received FDA breakthrough therapy designation for the treatment of rectal cancer.

The USA FDA has granted Breakthrough Therapy Designation (BTD) to its PD-1 inhibitor Jemperli (dostarlimab) for the treatment of locally advanced mismatch repair-deficient (dMMR)/high microsatellite instability (MSI-H) colorectal cancer.

Zhitong FinanceDec 19 08:17 ET

Express News | CA Governor Newsom Proclaimed State Of Emergency To Further Enhance State's Preparedness And Accelerate The Bird Flu Cross-Agency Response Efforts

BenzingaDec 18 14:45 ET

Express News | CDC Confirms First Severe Case Of H5N1 Bird Flu In U.S. On December 13; Patient Hospitalized With Severe Case Of Avian Influenza A Virus Infection In Louisiana

BenzingaDec 18 11:08 ET

Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers

GlobeNewswireDec 18 08:45 ET

Cautious Outlook on GlaxoSmithKline: Sell Rating Due to Pipeline and Financial Challenges

TipRanksDec 18 05:46 ET · Ratings

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT NewswiresDec 17 10:57 ET

GSK Gets CHMP Nod for Expanded Use of HIV Combo & Jemperli

Zacks Dec 17 10:05 ET

Deutsche Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)

TipRanksDec 17 08:25 ET · Ratings

What's Going On Moderna Stock On Monday?

BenzingaDec 16 13:10 ET

GSK's Jemperli Recommended for Expanded Approval in Endometrial Cancer, Receives Breakthrough Therapy Designation for Rectal Cancer

MT NewswiresDec 16 09:21 ET

GSK Passes Three Significant Milestones With New Cancer Drug Given a Double Boost | LSE:GSK, NYSE:GSK

Proactive InvestorsDec 16 03:18 ET